Decoding 7 Analyst Evaluations For Align Tech
In the preceding three months, 7 analysts have released ratings for Align Tech (NASDAQ:ALGN), presenting a wide array…
7 Analysts Assess Align Tech: What You Need To Know
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Align Tech…
Align Technology’s Invisalign Palatal Expander System Is Now Available In Australia And New Zealand For Skeletal And Dental Expansion In Growing Patients
Invisalign® Palatal Expanders offer doctors an effective and easily removable alternative to traditional palatal expanders, without the need for metal and screws.Combined with Invisalign First™ aligners,
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Looking Into Align Tech’s Recent Short Interest
Align Tech’s (NYSE:ALGN) short percent of float has fallen 18.06% since its last report. The company recently reported…
What Analysts Are Saying About Align Tech Stock
4 analysts have expressed a variety of opinions on Align Tech (NASDAQ:ALGN) over the past quarter, offering a…
Nasdaq Futures Rebound As Traders Eye Apple, Meta, Amazon Earnings: Analyst Flags ‘January Barometer’ That Bodes Well For The Year
After ending January with modest gains, the major averages now look to earnings catalysts to drive momentum, with futures higher in first trading session of February.
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 17.2% to $0.81 during Wednesday’s after-market session. Align Tech (NASDAQ:ALGN)…
Align Technology Q4 Earnings: Revenue Beat, EPS Beat, Strong Guidance And More
Align's fourth-quarter revenue increased 6.1% year-over-year to $956.7 million, which beat the consensus estimate of $933.67 million, according to Benzinga Pro. The company reported quarterly adjusted earnings of $2.42 per share, which beat analyst estimates of $2.18 per share.
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell
• Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.